19Jul/13

Wilmington woman reaches 50 gallons of blood donation – WWAY NewsChannel 3

Wilmington woman reaches 50 gallons of blood donation
WWAY NewsChannel 3
WILMINGTON, NC (WWAY) — The American Red Cross believes in donating where the need is greatest, and one Wilmington woman agrees and has for more than 60 years. “I can’t say what really, truly inspired me,” Carole Bryant said. “I mean, I was in the air 
Wilmington woman donates 50th gallon of bloodWECT-TV6
Summertime Leaves Red Cross In Urgent Need For DonorsKMUW

all 11 news articles »

19Jul/13

India joins UN in observing International Mandela Day United – Daily News & Analysis


Times of India

India joins UN in observing International Mandela Day United
Daily News & Analysis
India today joined UN member states in observing International Mandela Day on the 95th birthday of anti-apartheid icon Nelson Mandela with Prime Minister Manmohan Singh saying the day also holds special significance for the country. “On the occasion of
World pays tribute as ‘improving’ Mandela turns 95Times of India
Nelson Mandela ‘steadily improving’ as he marks his 95th birthdayGlobalnews.ca
South Africa marks Nelson Mandela’s 95th birthday, as he remains in ‘stable The Independent
The Week Magazine –Gospel Herald –Zee News
all 919 news articles »
19Jul/13

SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for … – PipelineReview.com (press release)

SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for
PipelineReview.com (press release)
Tell your doctor about all the medications you take including ORENCIA (abatacept), KINERET (anakinra), ACTEMRA (tocilizumab), RITUXAN (rituximab), or another TNF blocker, or if you are scheduled to or recently received a vaccine. People receiving 

and more »

19Jul/13

What Does Celgene Corporation (CELG)'s Failed Trial Mean for Investors? – Insider Monkey (blog)


Insider Monkey (blog)

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Insider Monkey (blog)
Biogen Idec Inc (NASDAQ:BIIB) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs

and more »